Skip to main content
Clinical Trials/ACTRN12620000838910
ACTRN12620000838910
Not yet recruiting
未知

Cough suppression therapy as a treatment for acute persistent cough following an upper respiratory tract infection

John Hunter Hospital0 sites101 target enrollmentAugust 24, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Common cold
Sponsor
John Hunter Hospital
Enrollment
101
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 24, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older.
  • Cough between 3 and 6 weeks duration following upper respiratory tract infection
  • Cough severity visual analogue scale\>39mm
  • Non\-productive cough
  • Probable viral infection as defined by the Common Cold Questionnaire

Exclusion Criteria

  • 1\.Primary diagnosis of history of cough secondary to lower airway disease
  • 2\.Haemoptysis
  • 3\.Productive cough of \> 1 table spoon phlegm per day.
  • 4\.Cystic fibrosis
  • 5\.Bronchiectasis/bronchitis
  • 6\.Chronic obstructive pulmonary disease
  • 7\.Interstitial lung disease
  • 8\.Cognitive impairment, poor English language skills or significant untreated hearing impairment that prevents completion of data collection forms or understanding verbal instructions.
  • 9\.Inability to attend study visits.
  • 10\.Current smoker or smoker with \>20 pack\-year smoking history

Outcomes

Primary Outcomes

Not specified

Similar Trials